DHI240705P110000
- 0.05
- 0.000.00%
D.R. Horton Newsroom
D.R. Horton Analyst Ratings
Citigroup Downgrades D.R. Horton to Neutral From Buy, Adjusts Price Target to $156 From $181
Citi: Maintains D.R. Horton (DHI.US) rating, adjusted from buy to buy rating, and adjusted the target price from $191.00 to $181.00.
D.R. Horton Analyst Ratings
Citigroup Adjusts Price Target on D.R. Horton to $181 From $191
Keefe, Bruyette & Woods: The D.R. Horton (DHI.US) rating was maintained, and the target price was adjusted from better than market to better than market, and the target price was adjusted from $172.00 to $178.00.
D.R. Horton Analyst Ratings
Keefe Bruyette & Woods Adjusts Price Target on D.R. Horton to $178 From $172
KBW Keeps Their Buy Rating on DR Horton (DHI)
Argus Adjusts Price Target on D.R. Horton to $165 From $160
D.R. Horton Analyst Ratings
BTIG: Maintains D.R. Horton (DHI.US) rating, adjusted from buy to buy rating, and adjusted target price from $169.00 to $168.00.
UBS: Maintaining the D.R. Horton (DHI.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $192.00 to $200.00.
D.R. Horton Analyst Ratings
D.R. Horton Earnings Beat Spurs Buy Rating Amid Positive Outlook and Resilient Margins
DR Horton (DHI) Receives a Rating Update From a Top Analyst
Buy Rating on D.R. Horton: Navigating Market Challenges With Operational Excellence
D.R. Horton Analyst Ratings
BTIG: Lowering Houghton House Target Price to $169 to Maintain “Buy” Rating
BTIG: Maintains D.R. Horton (DHI.US) rating, adjusted from buy to buy rating, and adjusted target price from $174.00 to $169.00.